The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
CONCLUSIONS: HLA-C*06:02 but not age at psoriasis onset is a predictive biomarker for biologic survival in psoriasis patients. Findings from this large cohort provide further, important information to aid clinicians using biologic therapies to manage psoriasis patients.PMID:38051972 | DOI:10.1093/bjd/ljad481
Source: The British Journal of Dermatology - Category: Dermatology Authors: Oras A Alabas Kayleigh J Mason Zenas Z N Yiu Richard B Warren Nick Dand Jonathan N Barker Catherine H Smith Christopher E M Grif fiths BADBIR study groups BSTOP study groups Source Type: research
More News: Dermatology | Enbrel | Humira | Ireland Health | Psoriasis | Skin | Stelara | Study | UK Health